biotech news today obesity drugs glp-1 Dozens of new are coming: these are the ones to watch Weight loss drugs: from dangers

Please follow these instructions carefully: Take immediately upon waking, on an empty stomach (at least 30 minutes before eating) Use no more than approx

Funding The research received no external funding

GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD

References 1.Baggio LL, Drucker DJ

Trials to date have focused on weight and metabolic outcomes, with lean mass reduction typically reported as a secondary endpoint and without standardized functional measures

Common GLP-1 Agonist Medications Several GLP-1 agonists have gained traction for blood sugar control and weight management, including: Dulaglutide (Trulicity) Tirzepatide (Mounjaro) Semaglutide (Ozempic and Wegovy) Liraglutide (Saxenda and Victoza) How GLP-1 Agonists Work So, how exactly do these medications work their magic